IOVANCE COO RSUs vest; shares withheld for taxes
IOVANCE BIOTHERAPEUTICS Chief Operating Officer Igor Bilinsky reported routine equity compensation activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IOVANCE BIOTHERAPEUTICS Chief Operating Officer Igor Bilinsky reported routine equity compensation activity. On the transaction date, 8,790 restricted stock units (RSUs) vested into an equal number of common shares. The company withheld 4,473 shares at $3.96 per share to cover mandatory tax obligations, which was not an open-market sale. Following these transactions, Bilinsky directly held 130,083 shares of common stock and 26,369 RSUs that will continue to vest in equal quarterly installments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 8,790 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,790 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,473 | $3.96 | $18K |
Footnotes (6)
- F1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- F2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- F3. Represents common stock remaining after deducting the common stock withheld for taxes.
- F4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F5. The remaining RSUs will vest in equal quarterly installments.
- F6. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding requirements financial
derivative security financial
contingent right financial
open market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did IOVA COO Igor Bilinsky report on this Form 4?
What happened to Igor Bilinsky’s restricted stock units (RSUs) in this IOVA filing?
Does the IOVA Form 4 show any open-market buying or selling by the COO?
AI-generated analysis. How Rhea-AI works. Not financial advice.